Corneal Transplant in China 2026: cost, tissue, aftercare
Corneal transplantation in China runs $4,000–7,500 per eye for a full-thickness or deep anterior lamellar graft and $4,500–9,000 for an endothelial graft (standard ranges, researched July 2026), against published US private-pay totals of $13,000–27,000. Cost, though, is the least difficult part of this decision. A graft depends on donated human tissue that nobody can promise on a date, and it commits you to monitoring for the rest of the eye's life. This page sets out the technique choices, the dated prices, and both of those constraints plainly — including the situations in which we would tell you not to travel.
PK / DALK $4,000–7,500 per eye · DSAEK $4,500–8,000 · DMEK $5,000–9,000 · keratoprosthesis quoted per case from about $9,000 · eye-bank tissue processing $800–2,000, itemised. Trip 2–3 weeks. Two hard conditions before we will plan anything: scheduling follows tissue availability, which no one can accelerate, and you need a named ophthalmologist at home who has agreed to take over aftercare. Anyone offering a guaranteed graft date, or advertising "no waiting list", is telling you something they cannot know.
Corneal tissue in China is donated voluntarily after death and distributed through eye banks operating under national eye-bank rules. (China's revised Regulation on Human Organ Donation and Transplantation, effective May 2024, governs solid organs and expressly does not extend to corneas and other tissue, which sit under the eye-bank framework — a distinction worth knowing if you are reading around this subject.)
The published record describes real scarcity rather than abundance. Studies of Chinese eye banks report that low willingness to pledge donation is the main constraint on supply: one of the country's largest eye banks recorded 8,023 preregistered donors but 1,955 actual donors across two decades, supplying 3,910 tissues of which roughly two-thirds were clinically usable; a provincial eye bank reports a utilisation rate near 88% in more recent years. Global donor-tissue shortage is itself a well-documented constraint on corneal transplantation.
Three consequences we hold to:
- We do not quote wait times and we do not promise dates. Scheduling follows tissue becoming available and passing screening. A concierge cannot change that, and a hospital marketing page claiming otherwise should worry you.
- Ask about provenance before you consent — which eye bank supplied the tissue, what consent and traceability documentation accompanies it, what screening was done. Reputable corneal units answer routinely and put the tissue record in your discharge papers. How readily you get that answer is itself information.
- "No waiting list" is a marketing claim, not a clinical one. You will see it on facilitator sites. It is the single strongest reason to look elsewhere.
Technique follows the pathology
"Corneal transplant" covers several different operations, and which one you need is decided by which layers of your cornea have failed — established on slit-lamp examination, corneal tomography and endothelial cell counts. Modern practice replaces only the diseased layers wherever possible.
| Your problem | Usual operation | What it means for you |
|---|---|---|
| Front-layer disease, healthy endothelium: keratoconus without full-thickness scarring, stromal scars and dystrophies | DALK (deep anterior lamellar keratoplasty) | Keeps your own endothelium, so endothelial rejection is not a risk; sutures stay in for many months |
| Endothelial failure alone: Fuchs dystrophy, bullous keratopathy after cataract surgery, some failed grafts | DSAEK or DMEK (endothelial keratoplasty) | Small incision, faster visual recovery, air/gas bubble in the eye — and therefore a flight restriction |
| Full-thickness scarring, perforation, or a failed graft with damage at every level | PK (penetrating keratoplasty) | Full-thickness graft; best long-term survival in comparative series but slowest and least predictable vision |
| Repeated graft failure with severe ocular-surface disease | Keratoprosthesis (artificial cornea) | A specialist salvage option with its own lifelong risks; discussed, not offered from a price list |
| Infected cornea perforating now | Emergency surgery where you are | A tectonic or therapeutic graft is emergency care — never a planned trip |
If a provider names your technique before examining your cornea, or quotes one price for "corneal transplant" without saying which operation, you are being sold a package rather than treatment.
What it costs (researched July 2026)
| Procedure | China (standard range) | US private-pay | Notes |
|---|---|---|---|
| Penetrating keratoplasty (PK), per eye | $4,000–7,500 | $13,000–27,000 | Includes theatre, surgeon, in-visit medication, scheduled reviews |
| DALK, per eye | $4,000–7,500 | $14,000–27,000 | Technically demanding; surgeon experience matters more than the price gap |
| DSAEK, per eye | $4,500–8,000 | $13,000–22,000 | Air/gas bubble used — plan the flight home around it |
| DMEK, per eye | $5,000–9,000 | $14,000–25,000 | Best visual results in series; highest rebubbling rate |
| Eye-bank tissue processing fee | $800–2,000 | $3,000–4,500 | Should be itemised separately on any written quote |
| Keratoprosthesis | From ~$9,000, per case | $25,000+ | Salvage cases only; quoted after specialist assessment |
| Combined graft + cataract surgery | +$800–1,500 | +$3,000–5,000 | Common in older eyes; one anaesthetic, one recovery |
| First-year monitoring visits, if done in China | $300–800 | $800–2,000 | Usually done at home instead — see aftercare below |
Ranges are standard partner-hospital fee schedules researched July 2026 against published US private-pay references; Western-European private rates typically sit 20–35% below the US figures. Ask for the tissue fee as a separate line — a quote that buries it is a quote you can't compare. For every other procedure, see the full China eye surgery price guide.
Published outcomes: a trade-off, not a winner
The honest summary of the comparative literature is that the techniques trade survival against vision. In a ten-year comparative series, penetrating keratoplasty showed the best long-term graft survival at around 92%, against roughly 75% for DMEK and 73% for DSAEK — while the endothelial techniques gave far better and faster sight, with about 93% of DMEK eyes reaching 6/12 or better within five years compared with 63% after penetrating keratoplasty. Endothelial cell loss of 30–60% in the first year after DMEK is expected rather than exceptional. Graft detachment needing a further bubble injection occurs in roughly 20% of DMEK and 15% of DSAEK cases in published series.
Two caveats that matter more than the averages. First, survival is indication-dependent: keratoconus grafts do best, while repeat grafts and inflamed or vascularised eyes do considerably worse — so ask your surgeon for figures relevant to your diagnosis, not the headline number. Second, none of this is a guarantee for an individual eye, and a surgeon who offers one is not describing corneal surgery as it is practised anywhere.
A corneal graft is a lifelong relationship with an eye clinic, not a procedure you complete. Rejection can occur at any point in a graft's life — months or years later — and its early signs need a corneal specialist who can see you within days:
- Redness that is new or worsening · Sensitivity to light · Vision dropping · Pain. Any of these after a graft means be seen urgently, wherever you are.
- Steroid drops tapered over many months and often continued at low dose for years, with pressure checks because steroids can raise eye pressure.
- Sutures after PK or DALK may stay a year or more and need removal or selective adjustment by a corneal specialist — that will happen at home, not in China.
So the sequence is: find and confirm your home corneal specialist first, then plan surgery. If nobody at home has agreed to take over the drops, the pressure checks, the suture management and the rejection surveillance, travelling for a graft is not a plan we will help you execute — and that is a deliberate limit, not a formality.
The trip, and the flight home
| Pathway | Time in China | Shape of the visit |
|---|---|---|
| Assessment / second opinion only | 2–4 days | Slit-lamp examination, tomography, endothelial cell count, written technique recommendation and alternatives |
| DMEK / DSAEK | 2–3 weeks | Work-up, surgery once tissue is available, face-up positioning, bubble monitoring, possible rebubbling, reviews before clearance |
| PK / DALK | 2–3 weeks | Work-up, surgery, early suture and pressure checks, refraction expectations set for the long haul |
The flight restriction to plan around: endothelial grafts are held in place with an air or gas bubble, and flying is not permitted while that bubble is present because cabin pressure changes expand gas. Your surgeon confirms absorption before clearing you. Our flying-after-eye-surgery guide explains the physics and the per-procedure windows. Because surgery is scheduled around tissue availability, book changeable tickets and accommodation — this is the one eye procedure where a fixed itinerary is the wrong instinct.
Before accepting a transplant recommendation
Grafts are the right answer for many corneas and a premature answer for some. If your diagnosis is keratoconus, the conversation usually runs through cross-linking to halt documented progression, rigid or scleral contact lenses to correct vision glasses can't, and intracorneal ring segments in selected corneas — with a graft reserved for corneas too scarred, thin or irregular for those to give usable sight. Our keratoconus treatment guide covers all three in detail, including what evidence of progression a surgeon should want before treating you. If your diagnosis is Fuchs dystrophy, mild cases are monitored for years before anyone operates. Fair questions to put to any surgeon, anywhere:
- Which layers of my cornea have failed, and what measurement shows that?
- What non-transplant options were considered, and why were they ruled out?
- Which technique, and what are your outcomes for my indication?
- What does the drop and review schedule look like in year one, and in year five?
- What happens if this graft fails — what is the next option?
Where the work is done matters as much as what it costs: corneal transplantation belongs in dedicated corneal units with an eye bank relationship and their own tissue-handling standards, which in China means the corneal services of the major academic eye centres. Our best eye hospitals guide profiles those institutions, the for-foreigners guide covers international departments, records and payment, and the city comparison weighs access and flights. Our safety assessment addresses the standards question directly, and if your case turns out to sit elsewhere, the glaucoma & retina guide and cataract guide cover the neighbouring pathways.
Frequently asked questions
How much does a corneal transplant cost in China?
PK and DALK $4,000–7,500 per eye, DSAEK $4,500–8,000, DMEK $5,000–9,000, keratoprosthesis from about $9,000 per case, with eye-bank tissue processing itemised at $800–2,000 (standard ranges, researched July 2026) — against published US private-pay totals of $13,000–27,000 per eye. Technique drives price and is a clinical decision.
Can anyone guarantee when donor tissue will be available?
No, and we won't. Tissue is voluntarily donated after death and distributed by eye banks; the published literature describes genuine scarcity, with low pledge willingness as the main constraint. Scheduling follows availability and screening. Treat guaranteed dates and "no waiting list" claims as reasons to walk away.
How do I check where the tissue came from?
Ask in writing before consenting: which eye bank supplied it, what consent and traceability documentation accompanies it, and what screening was performed. Reputable corneal units answer routinely and include the tissue record in your discharge documents.
Which technique will I need?
The one matching the failed layers: DALK for front-layer disease with a healthy endothelium, DSAEK or DMEK for endothelial failure, PK for full-thickness damage or a failed graft, keratoprosthesis for repeated failure with severe surface disease. Decided after examination, tomography and cell counts.
What are the published survival rates?
A trade-off: about 92% ten-year graft survival for PK versus roughly 75% DMEK and 73% DSAEK in a comparative series, while DMEK gave much better vision (about 93% reaching 6/12 within five years versus 63% for PK). Survival is strongly indication-dependent — keratoconus best, repeat and inflamed eyes worst.
What does aftercare involve?
Steroid drops tapered over months and often continued for years with pressure checks, scheduled examinations, and sutures that may stay a year or more after PK or DALK. Rejection can happen at any time, so a named home ophthalmologist who has agreed in advance to take over is a precondition for travelling, not an afterthought.
How soon can I fly?
After DSAEK or DMEK, not while the air or gas bubble is in the eye — cabin pressure expands gas, and rebubbling is needed in roughly 20% of DMEK and 15% of DSAEK cases. PK and DALK have no gas restriction but need several reviews first. Expect 2–3 weeks in China, with clearance from the operating surgeon.
I have keratoconus — do I need a graft?
Most people never do. Cross-linking aims to halt documented progression, and rigid or scleral lenses correct vision glasses can't; rings help selected corneas. A graft becomes the conversation only when the cornea is too scarred, thin or irregular for those to give usable vision. Ask what alternatives were considered.